Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000592438 | SCV000708797 | pathogenic | not provided | 2017-05-30 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000674384 | SCV000799709 | likely pathogenic | DE SANCTIS-CACCHIONE SYNDROME; Cerebrooculofacioskeletal syndrome 1; Cockayne syndrome type 2 | 2018-05-02 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000592438 | SCV001582266 | pathogenic | not provided | 2023-10-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg947*) in the ERCC6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC6 are known to be pathogenic (PMID: 18628313, 29572252). This variant is present in population databases (no rsID available, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with Cockayne syndrome (PMID: 29572252). ClinVar contains an entry for this variant (Variation ID: 502165). For these reasons, this variant has been classified as Pathogenic. |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000592438 | SCV001952558 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000592438 | SCV001964865 | pathogenic | not provided | no assertion criteria provided | clinical testing |